We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Developing a COVID-19 Vaccine: Cobra Biologics Part of ChAdOx1 Consortium

Product News   Apr 01, 2020

 
Developing a COVID-19 Vaccine: Cobra Biologics Part of ChAdOx1 Consortium
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Novavax Awarded Department of Defense Contract for COVID-19 Vaccine

Product News

Novavax, Inc. has announced that the company has been awarded a contract by the U.S. Department of Defense for the manufacturing of NVX CoV2373, Novavax’ COVID-19 vaccine candidate.

READ MORE

Immune Responsive Nanoparticles for COVID-19 Vaccine Delivery

Product News

Analytik reports how the Quadram Institute has invested in a ZetaView Nanoparticle Tracking Analyser to help them develop a new approach for vaccine delivery based on engineering the natural ability of resident gut bacteria to generate nanoparticle sized Outer Membrane Vesicles.

READ MORE

IRBM’s Advent Manufactures 13,000 Doses of COVID-19 Vaccine for Use in Phase 2/3 Clinical Trials

Product News

Advent has manufactured 13,000 doses of the novel COVID-19 vaccine candidate, ChAdOx1 nCoV-19 (now known as AZD1222) for use in the Phase 2/3 clinical trial COV002 by the University of Oxford.

READ MORE

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE